Patterns and Adherence to GOLD-Recommended Inhaled Therapy in Chronic Obstructive Pulmonary Disease (COPD) Patients with Acute Exacerbation History in Primary Care in China
Among the COPD patients with a history of acute exacerbations at primary care, prescribing frequently diverged from GOLD 2023 recommendations, characterized by high rates of No inhaled therapy and widespread use of ICS-containing regimens in groups A and B, necessitating improved prescription guideline adherence in the future to facilitate the implementation of standardized COPD management.
Authors
- Chunhua Chi (ORCID: https://orcid.org/0000-0003-3566-5582)
- Xueying Li (ORCID: https://orcid.org/0000-0002-9609-1984)
- Mi Yao (ORCID: https://orcid.org/0009-0003-0604-600X)
- Jin Xue (ORCID: https://orcid.org/0000-0002-5527-8638)
- Jiapei Xu
- Qiaoli Su
- Jingyu Hao
- Jing Ma
- Jiao Xu
- Guanning Jing
- Hongjing Pei
- Ying Wang
- Jingyi Ye
- Yujing Su
Institutions
- Peking University (CN)
- Sichuan University (CN)
- West China Medical Center of Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
- Beijing Institute of Big Data Research (CN)
- Peking University First Hospital (CN)
Publication Details
- Journal
- International Journal of COPD
- Published
- 2026-02-01
- DOI
- https://doi.org/10.2147/copd.s566724
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Key Research and Development Program of China